Appointed as President Commissioner and Independent Commissioner for the first period based on the Resolution of the Extraordinary General Meeting of Shareholders (EGMS) of the Company on December 17, 2024 to serve until the 2028 Financial Year GMS.
Completed his Bachelor Degree Bachelor of Science of Pharmacy education at Rijksuniversiteit Utrecht, Netherlands in 1975 and Master of Business Administration at Rotterdam School of Management, Netherlands in 1984. Some of the positions he has held are President Director of PT Solusi Periferal (1990-present), President Director of PT Autojaya ID Tech (1989-present), and President Director of PT Kertas Nusantara (2004-2009).
Appointed as Independent Commissioner for the first period based on the Resolutions of the 2019 Annual General Meeting of Shareholders (GMS) on 29 July 2020 to serve until the 2024 Fiscal Year GMS.
He earned a doctorate at the Faculty of Medicine, Sriwijaya University, Palembang before becoming the Presidential Doctor of the Republic of Indonesia until now. Completed medical education specialist studies in Anesthesiology & Intensive Therapy at UGM & Masters in Hospital Management at the same University. His previous positions were Director of Operations at PT Pertamedika Holding Company Group RS Pertamina (2014-2017), Presidential Doctor (2014-present) and Expert Staff to the Board of Directors of PT Pertamedika (2014)
Appointed as Commissioner for the first period based on the Resolutions of the Annual General Meeting of Shareholders (GMS) for Fiscal Year 2021 on May 11, 2022 to serve until the GMS for Fiscal Year 2026.
Finished the study of Doctor of Philosophy (PhD) in 1995 from Colorado State University (CSU) of the United States of America, Master of Science (MSc) in 1990 from Colorado State University (CSU) of the United States of America, and Veterinarian (drh) from Bogor Agricultural Institute (IPB) in 1998. In addition to that, he also finished the study at the National Resilience Institute of The Republic of Indonesia (Lemhannas RI) (PPSA-18) in 2012.
He is the Government’s Spokesman and Coordinator of the Expert Team of the COVID-19 Handling Task Force, Coordinator of the Expert Team of Foot and Mouth Disease Handling Task Force at BNPB, Member of Board of Trustees of the University of Indonesia, as well as Lecturer and Professor of Health Policy at the University of Indonesia’s Faculty of Public Health. In addition to that, he is also the founder of Indonesia One Health University Network.
In the international world, he is the member of One Health High Level Expert Panel (OHHLEP) from WHO, FAO, WOAH, UNEP, and also an Adjunct Professor at Tufts University of the United States of America.
Appointed as Commissioner for the first period based on the Resolutions of the Annual General Meeting of Shareholders (GMS) for Fiscal Year 2020 on April 28, 2021 to serve until the GMS for Fiscal Year 2025.
Completed his Masters in Law from the University of Indonesia and his Bachelor's degree from the University of Borobudur. His previous positions were Assistant Deputy for Risk Management and Compliance at the Ministry of SOEs, Commercial Director at PT Petrokimia Gresik (2017-2021), Commissioner at PT Angkasa Pura I (Persero) (2014-2017), and Assistant Deputy for Risk Management and Compliance at the Ministry of SOEs. Republic of Indonesia (2021 - present)
Appointed as Independent Commissioner for the first period based on the Resolution of the Extraordinary General Meeting of Shareholders (EGMS) of the Company on December 17, 2024 to continue serving until the GMS for the Financial Year 2026.
Completed his Bachelor Degree in Medicine, Sriwijaya University and Master Doctorate in Public Health, University of Indonesia. His previous positions were President Director of BPJS Kesehatan (2014-2021), President Director of PT Askes (2013-2014), and Board of Commissioners of PT Askes (2008-2013).
Appointed as Independent Commissioner for the first period based on the Resolution of the Extraordinary General Meeting of Shareholders (EGMS) of the Company on October 13, 2023 to serve until the GMS for the Financial Year 2028.
She is completing his Bachelor Degree in Universitas Jayabaya. Her previous positions were Corporate Secretary PT Bravo Alam Synergy (2019-2023) and Corporate Secretary PT Sojitz Indonesia (2000-2019)
Appointed as Commissioner for the first period based on the Resolution of the Extraordinary General Meeting of Shareholders (EGMS) of the Company on December 17, 2024 to serve until the GMS for the Financial Year 2028.
Completed his D4 Accounting, STAN University in 1993 and his Masters in Public Administration at Universitas Gadjah Mada in 2005. His previous positions were Commissioner of PT Jasa Raharja (2018-2023), Commissioner of PT Asuransi Kerugian Jasa Raharja (2018-2022), and Commissioner of PT Permodalan Nasional Madani (2017-2018).
PT. KIMIA FARMA, TBK
Jl. Veteran NO. 9
Jakarta Pusat - 10110
24 hours
© 2024 - Kimia Farma. All Right Reserved.